Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,151.00$ -1.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Eli Lilly and Company (LLY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 22,974 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LLY
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	5,192	5,761	5,228	5,824	5,658	6,161	4,964	5,585	5,307	6,439	5,092	5,637	5,477	6,114	5,860	5,499	5,741	7,440	6,806	6,740	6,773	8,000	7,810	6,488	6,942	7,302	6,960	8,312	9,499	9,353	8,768	11,303	11,439	13,533	12,729	15,558	17,601	19,292	19,799	22,974	79,666
Cost of Revenue	1,401	1,466	1,348	1,572	1,586	1,625	1,165	1,234	1,153	1,594	1,139	1,125	1,175	1,283	1,215	1,222	1,326	1,720	1,879	1,953	1,431	2,050	2,072	1,431	1,579	1,548	1,627	1,807	1,860	1,788	1,674	2,170	2,171	2,404	2,224	2,448	3,008	2,884	3,577	3,268	12,737
Gross Profit	3,791	4,295	3,880	4,253	4,072	4,536	3,799	4,351	4,154	4,845	3,954	4,512	4,302	4,831	4,645	4,277	4,414	5,720	4,927	4,787	5,342	5,950	5,738	5,058	5,363	5,754	5,333	6,505	7,639	7,565	7,095	9,133	9,268	11,129	10,504	13,110	14,593	16,408	16,222	19,706	66,929
Research & Development	1,236	1,451	1,258	1,272	1,340	1,473	1,108	1,271	1,281	1,454	1,231	1,402	1,381	1,581	1,392	1,390	1,465	1,838	1,672	1,655	1,705	1,959	1,610	1,782	1,803	1,996	1,985	2,357	2,409	2,563	2,523	2,711	2,734	3,023	2,734	3,336	3,466	3,802	3,510	3,819	14,597
Selling, General & Administrative	1,565	1,790	1,505	1,666	1,515	2,294	1,283	1,431	1,395	1,794	1,461	1,537	1,360	1,646	1,505	1,413	1,455	1,497	1,503	1,615	1,505	1,519	1,465	1,531	1,522	1,550	1,633	1,810	1,688	1,810	1,836	2,003	1,984	2,309	2,362	2,648	2,741	3,344	2,934	3,430	12,448
Total Operating Expenses	2,802	3,241	2,763	2,938	2,855	3,767	2,390	2,702	2,676	3,247	2,692	2,939	2,741	3,228	2,897	2,803	2,921	3,335	3,175	3,270	3,211	3,479	3,075	3,313	3,325	3,546	3,619	4,166	4,098	4,372	4,359	4,714	4,719	5,331	5,096	5,984	6,206	7,633	7,372	10,728	31,939
Operating Income	989	1,054	1,118	1,314	1,217	769	1,409	1,649	1,478	1,598	1,262	1,573	1,561	1,604	1,748	1,475	1,494	2,386	1,752	1,517	2,131	2,471	2,663	1,745	2,038	2,208	1,715	2,338	3,541	3,193	2,736	4,419	4,550	5,798	5,408	7,126	8,386	8,775	8,850	8,978	34,989
Interest Expense	47	51	47	54	62	63	61	63	61	78	87	111	107	96	93	88	90	89	88	87	84	81	85	81	82	84	103	120	125	138	180	184	193	225	244	249	180	123	332	345	980
Pre-Tax Income	971	892	61	1,261	592	284	1,366	42	1,341	939	731	1,466	1,406	1,663	1,680	1,644	1,437	2,469	1,476	1,594	1,245	1,840	2,054	1,091	1,566	2,096	1,530	2,089	427	2,509	2,536	3,517	1,588	5,039	3,456	6,776	7,232	8,265	8,850	9,247	33,594
Income Tax Expense	193	120	172	253	36	1,941	199	273	248	-186	170	139	152	167	223	232	229	352	121	204	135	114	151	138	114	159	185	326	485	319	293	550	618	629	697	1,116	1,650	1,629	1,454	2,152	6,885
Net Income	778	772	-111	1,008	556	-1,657	1,217	-260	1,150	1,125	4,242	1,327	1,254	1,496	1,457	1,412	1,208	2,117	1,355	1,390	1,110	1,726	1,903	953	1,452	1,938	1,345	1,763	-57	2,190	2,243	2,967	970	4,410	2,759	5,661	5,583	6,636	7,396	7,095	26,710
EBITDA	1,411	1,288	495	1,710	1,026	759	1,850	530	1,817	1,363	1,174	1,824	1,801	2,100	2,046	2,056	1,885	2,926	1,915	2,050	1,711	2,367	2,574	1,521	2,010	2,555	1,995	2,576	963	3,035	3,116	4,115	2,248	5,748	4,163	7,504	7,882	8,388	9,691	9,247	35,208

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings